Orbis Investment Management (US)’s Gilead Sciences GILD Stock Holding History

Orbis Investment Management (US)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-13,389	Closed	-$1.57M	–	24
2015 Q2	$1.57M	Sell	13,389 -38,135	-74%	-$4.17M	1.26%	22
2015 Q1	$5.06M	Sell	51,524 -11,534	-18%	-$1.17M	4.15%	12
2014 Q4	$5.94M	Sell	63,058 -638	-1%	-$66K	4.93%	7
2014 Q3	$6.78M	Sell	63,696 -27,200	-30%	-$2.66M	5.63%	5
2014 Q2	$7.54M	Buy	90,896 +51,824	+133%	+$4.03M	6.25%	4
2014 Q1	$2.77M	Buy	39,072 +16,249	+71%	+$1.27M	2.52%	19
2013 Q4	$1.72M	Buy	+22,823	New	+$1.59M	1.57%	28

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Orbis Investment Management (US)'s GILD Position: Q3 2015 in Review

Orbis Investment Management (US) sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 13,389 shares — an estimated $1.57M sold.

Orbis Investment Management (US) first reported a position in GILD in Q4 2013 and held it in 7 quarters. The position peaked at $7.54M in Q2 2014. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Orbis Investment Management (US) reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
Orbis Investment Management (US) sold 13,389 Gilead Sciences shares in Q3 2015, an estimated $1.57M.
Orbis Investment Management (US) first reported a position in Gilead Sciences in Q4 2013 and held it in 7 quarters.
Orbis Investment Management (US)'s Gilead Sciences position peaked at $7.54M in Q2 2014.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Orbis Investment Management (US)'s 13F filing for Q3 2015, filed 16 Nov 2015.